Get access

Pegylated liposomal doxorubicin for relapsed ovarian cancer

  • Protocol
  • Intervention



This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy of pegylated liposomal doxorubicin in all patients with relapsed epithelial ovarian cancer used by itself or in combination, including patients with both platinum sensitive and resistant disease.

Get access to the full text of this article